Harry L. Leider - Net Worth and Insider Trading
Harry L. Leider Net Worth
The estimated net worth of Harry L. Leider is at least $9,445 dollars as of 2024-10-30. Harry L. Leider is the CEO of Zeo ScientifiX Inc and owns about 5,247 shares of Zeo ScientifiX Inc (ZEOX) stock worth over $9,445. Details can be seen in Harry L. Leider's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harry L. Leider has not made any transactions after 2023-06-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Harry L. Leider
Harry L. Leider Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harry L. Leider owns 2 companies in total, including Gelesis Holdings Inc (GLSHQ) , and Zeo ScientifiX Inc (ZEOX) .
Click here to see the complete history of Harry L. Leider’s form 4 insider trades.
Insider Ownership Summary of Harry L. Leider
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GLSHQ | Gelesis Holdings Inc | 2022-01-13 | Chief Medical Officer |
ZEOX | Zeo ScientifiX Inc | 2023-06-29 | director & CEO and Director |
Harry L. Leider Latest Holdings Summary
Harry L. Leider currently owns a total of 1 stock. Harry L. Leider owns 5,247 shares of Zeo ScientifiX Inc (ZEOX) as of June 29, 2023, with a value of $9,445.
Latest Holdings of Harry L. Leider
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZEOX | Zeo ScientifiX Inc | 2023-06-29 | 5,247 | 1.80 | 9,445 |
Holding Weightings of Harry L. Leider
Harry L. Leider Form 4 Trading Tracker
According to the SEC Form 4 filings, Harry L. Leider has made a total of 1 transactions in Zeo ScientifiX Inc (ZEOX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zeo ScientifiX Inc is the acquisition of 5,247 shares on June 29, 2023, which cost Harry L. Leider around $10,495.
Insider Trading History of Harry L. Leider
- 1
Harry L. Leider Trading Performance
GuruFocus tracks the stock performance after each of Harry L. Leider's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harry L. Leider is -2%. GuruFocus also compares Harry L. Leider's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harry L. Leider within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harry L. Leider's insider trading performs compared to the benchmark.
Performance of Harry L. Leider
Harry L. Leider Ownership Network
Ownership Network List of Harry L. Leider
Ownership Network Relation of Harry L. Leider
Harry L. Leider Owned Company Details
What does Gelesis Holdings Inc do?
Who are the key executives at Gelesis Holdings Inc?
Harry L. Leider is the Chief Medical Officer of Gelesis Holdings Inc. Other key executives at Gelesis Holdings Inc include Genrl Counsel & CCO & Secretary David Abraham , 10 percent owner Andrew D. Wingate , and 10 percent owner Puretech Health Llc .
Gelesis Holdings Inc (GLSHQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Gelesis Holdings Inc (GLSHQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gelesis Holdings Inc (GLSHQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Gelesis Holdings Inc (GLSHQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gelesis Holdings Inc Insider Transactions
Harry L. Leider Mailing Address
Above is the net worth, insider trading, and ownership report for Harry L. Leider. You might contact Harry L. Leider via mailing address: C/o Gelesis, Inc., 501 Boylston Street, Suite 6102, Boston Ma 02116.